ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $157,000 | +37.7% | 1,683 | -11.5% | 0.00% | – |
| Q3 2021 | $114,000 | -11.6% | 1,902 | +1.5% | 0.00% | – |
| Q2 2021 | $129,000 | -9.2% | 1,874 | -8.4% | 0.00% | – |
| Q1 2021 | $142,000 | -31.7% | 2,045 | -24.2% | 0.00% | -100.0% |
| Q4 2020 | $208,000 | -3.3% | 2,699 | -11.3% | 0.00% | 0.0% |
| Q3 2020 | $215,000 | +20.1% | 3,044 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $179,000 | +53.0% | 2,866 | -1.2% | 0.00% | – |
| Q1 2020 | $117,000 | – | 2,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
| PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
| Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
| Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
| DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
| Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
| First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
| Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
| Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
| Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |